Activery The amorphization specialist
Activery believes that amorphous drugs provide new and innovative routes to final dosage forms with differentiated pharmacokinetics
Activery believes that amorphous drugs provide new and innovative routes to final dosage forms with differentiated pharmacokinetics
In Activery we believe that solid state modifications may lead to a critical changes in your active pharmaceutical, thus to a differentiated drug or to a brand new innovative medicine
Activery possess unrivalled specialist expertise about different crystallization techniques and expert knowledge in the field of solid state modulation.
In Activery, we design and produce particles for special uses where size matters such as nanoparticles for cancer treatment. Through our technology you would enable new administration routes or renewed performance of your drug formulation.
|
|
|
Good Manufacturing Practices (GMP) in ActiveryGood Manufacturing Practices or GMP is a must for manufacturing pharmaceutical products such as nanoparticles and microparticles and modified API (Active Pharmaceutical Ingredients). As Activery wants to be a critical player in the pharmaceutical market, soon, Activery will have its own cGMP compliant facilities to provide powders suitable for human clinical trials in Navarra (Spain) Phone: +34 935947011 E-mail: contactus @ activery.com |